-
Celebrex “Black Box” Label Warning About Increased Cardiovascular Risks
"Class Effect": Like Bextra and Vioxx, Celebrex Can Cause Heart Attacks and Strokes The pharmaceutical company Pfizer Inc. announced on August 1, 2005 that the FDA had finalized a new label for the arthritis…
-
Hormonal Menopausal Therapy Classified as Carcinogenic by IARC
U.N. Research Agency Determines Hormone Therapy Regimen Slightly Raises Risk of Some Cancers In late July 2005, the International Agency for Research on Cancer — the United Nations’ cancer agency — announced its new…
-
Vioxx-related Heart Attack Risk Increased After Just A Few Weeks Use, Not 18 Months?
"New" Liability Document Will be Important In NJ Vioxx Case Scheduled for September 2005 On July 26, 2005 The Wall Street Journal reported that plaintiff attorneys in a New Jersey Vioxx lawsuit are expected…
-
At Least 4.3 Million Adverse Drug Events (ADEs) for U.S. Patients in 2001
Adverse Drug Reactions are a "significant threat to patient safety in the United States" Adverse drug events (ADEs) involving prescription drugs resulted in an estimated 4.3 million doctor visits by affected patients in the…
-
Health Canada Issues Warning About Vision Loss Related to Viagra, Cialis, and Levitra
Two Case Reports of NAION in Canada Prompt Drug-safety Alert on ED Drugs On July 26, 2005 Health Canada advised users of the erectile dysfunction drugs Viagra, Cialis, and Levitra to seek "immediate medical…
-
Psoriasis Drug Raptiva Increases the Risk of Serious Infections
July 2005 "Dear Doctor" Letter Warns About Some Blood Disorders, Also Genentech Inc. and the FDA announced recently that the drug company had added a new warning for the psoriasis drug Raptiva about an…
